Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases

Collaboration to make use of…

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19.

ExeVir Bio and VIB-UGent’s bioRxiv…

Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554

Confo to receive upfront and…

Cellaion SA announces a total fundraising of EUR 23 million in 2022 for its phase IIB study in Acute on Chronic Liver Failure with Truffle Capital as lead investor in the final Closing followed by Newton Biocapital, Wallonie Entreprendre and individual investors.

Mont-Saint-Guibert, Belgium, 2023/01/13. Cellaïon is…

TargED Biopharmaceuticals announces the appointment of Erik van den Berg as Chair of its Supervisory Board

Utrecht, the Netherlands, January 19,…

Belgium: ExeVir lands European venture debt financing to develop novel nanobody COVID-19 therapy

ExeVir signs €25 million venture debt…

Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief Medical Officer

Mont Saint-Guibert, Belgium – December…

Novadip Biosciences SA Announces Positive Results from Phase 1/2 Clinical Trial in Patients with Severe Bone Non-Union of the Lower Limb Following Trauma

Study results demonstrate NVD-003 has…

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe9

The companies enter into a…

Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million

Funding will support development of…